These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12492726)
1. Impact and modulation of nasal obstruction. Horak F Allergy; 2002; 57 Suppl 75():25-8. PubMed ID: 12492726 [TBL] [Abstract][Full Text] [Related]
2. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. Horak F; Stübner UP; Zieglmayer R; Harris AG J Allergy Clin Immunol; 2002 Jun; 109(6):956-61. PubMed ID: 12063524 [TBL] [Abstract][Full Text] [Related]
3. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine. Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609 [TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Bachert C Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095 [TBL] [Abstract][Full Text] [Related]
5. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861 [TBL] [Abstract][Full Text] [Related]
6. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Raphael GD; Angello JT; Wu MM; Druce HM Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933 [TBL] [Abstract][Full Text] [Related]
8. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Greiff L; Persson CG; Andersson M Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387 [TBL] [Abstract][Full Text] [Related]
9. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Nayak AS; Schenkel E Allergy; 2001 Nov; 56(11):1077-80. PubMed ID: 11703222 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Berger WE; Schenkel EJ; Mansfield LE; Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion. Schenkel E; Corren J; Murray JJ Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis. Grubbe RE; Lumry WR; Anolik R J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Canonica GW; Tarantini F; Compalati E; Penagos M Allergy; 2007 Apr; 62(4):359-66. PubMed ID: 17362245 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Horak F; Stübner P; Zieglmeyer R; Harris AG Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447 [TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441 [TBL] [Abstract][Full Text] [Related]
16. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. Pleskow W; Grubbe R; Weiss S; Lutsky B Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies. Bachert C; Maurer M Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329 [TBL] [Abstract][Full Text] [Related]
20. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis. Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]